Saliva Estriol Levels in Women with and Without Prenatal Antidepressant Treatment

Biological Psychiatry

Volumn 64, Issue 6, 2008, Pages 533-537

  Suri, Rita ^a   Hellemann, Gerhard ^a   Cohen, Lee ^a   Aquino, Ana ^a   Altshuler, Lori ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressants; estriol; pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT; ESTRIOL;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EXPOSURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREGNANCY; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; SALIVA LEVEL;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ESTRIOL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MIDDLE AGED; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SALIVA; YOUNG ADULT;

EID: 49749088340     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.04.015     Document Type: Article

References (36)

1. Gilbert W. The cost of preterm birth: The low cost versus high value of tocolysis. BJOG 113 Suppl 3 (2006) 4-9
2. Wang M.L., Dorer D.J., Fleming M., and Catlin E.A. Clinical outcomes of near-term infants. Pediatrics 114 (2004) 372-376
3. Gilbert W.M., Nesbitt T.S., and Danielsen B. The cost of prematurity: Quantification by gestational age and birth weight. Obstet Gynecol 102 (2003) 488-492
4. Underwood M.A., Danielsen B., and Gilbert W.M. Cost, causes and rates of rehospitalization of preterm infants. J Perinatol 27 (2007) 614-619
5. Hedriana H.L., Munro C.J., Eby-Wilkens E.M., and Lasley B.L. Changes in rates of salivary estriol increases before parturition at term. Am J Obstet Gynecol 184 (2001) 123-130
6. Heine R.P., McGregor J.A., Artel M., Heine R., Hayashi R.H., Robertson P.A., and Varner M.W. Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol 96 (2000) 490-497
7. McGregor J.A., Jackson G.M., Lachelin C.L., Goodwin T.M., Artal R., et al. Salivary estriol as risk assessment for preterm labor: A prospective trial. Am J Obstet Gynecol 173 (1995) 1337-1342
8. Ramsey P.S., and Andrews W.W. Biochemical predictors of preterm labor: Fetal fibronectin and saliva estriol. Clin Perinatol 30 (2003) 701-733
9. Chambers C.D., Johnson K., Dick L., Felix R., and Jones K.L. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 (1996) 1010-1015
10. Costei A.M., Kozer E., Ho T., Ito S., and Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 156 (2001) 1129-1132
11. Ferreira E., Carceller A.M., Agogue C., Martin B.Z., St-Andre M., Francoeur D., and Berard A. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 119 (2007) 52-59
12. Ericson A., Kallen B., and Wiholm. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 55 (1999) 503-508
13. Simon G.E., Cunningham M.L., and Davis R.L. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 159 (2002) 2055-2061
14. Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 158 (2004) 312-316
15. Suri R., Altshuler L., Helleman G., Burt V.K., Aquino A., and Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 164 (2007) 1206-1213
16. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) (1995), Biometrics Research, New York State Psychiatric Institute, New York
17. Williams J.B. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 45 (1988) 742-747
18. Cohen S., Kamarck T., and Mermelstein R. A global measure of perceived stress. J Health Soc Behav 24 (1983) 385-396
19. Mauldin J.G., and Newman R.B. Preterm birth risk assessment. Seminars in perinatology 25 (2001) 215-222
20. Darne J., McGarrigle H.H., and Lachelin G.C. Saliva estriol, oestradiol, oestrone and progesterone levels in pregnancy: Spontaneous labour at term is preceded by a rise in saliva oestriol progesterone ratio. Br J Obstet Gynaecol 94 (1987) 227-235
21. McGarrigle H.H.G., and Lachelin G.C.L. Increasing saliva (free) oestriol to progesterone ratio in late pregnancy: A role for oestriol in initiating spontaneous labour in man. BMJ 289 (1987) 457-459
22. Darne J., McGarrigle H.H.G., and Lachelin G.C.L. Increased saliva oestriol to progesterone ratio before idiopathic preterm delivery: A possible predictor for preterm labour?. BMJ 294 (1987) 270-272
23. Goffinet F., Maillard F., Fulla Y., and Cabrol D. Biochemical markers (without markers of infection) of the risk of preterm delivery: Implications for clinical practice. Eur J Obstetr Gynecol Reproduct Biol 94 (2001) 59-68
24. Goodwin T.M. A role for estriol in human labor, term and preterm. Am J Obstet Gynecol 180 (1999) S208-S213
25. Karalis K., Goodwin G., and Majzoub J.A. Cortisol blockade of progesterone: A possible mechanism involved in the initiation of human labor. Nat Med (1996) 556-560
26. Speroff L., Glass R.H., and Kase N.G. The endocrinology of pregnancy. In: Speroff L., Glass R.H., and Kase N.G. (Eds). Clinical Gynecologic Endocrinology and Infertility (1994), Williams and Wilkins, New York 251-289
27. Fuchs F. Endocrinology of parturition. Endocrinology of Pregnancy. 3rd ed. (1983), Harper and Row, New York 247-270
28. Garfield R.E., and Hayashi R.H. Appearance of gap junctions in the myometrium of women during labor. Am J Obstet Gynecol 140 (1981) 254-260
29. Brady L.S., Whitfield Jr. H.J., Fox R.J., Gold P.W., and Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain: Therapeutic implications. J Clin Invest 87 (1991) 831-837
30. Brady L.S., Gold P.W., Herkenham M., Lynn A.B., and Whitfield Jr. H.J. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications. Brain Res 572 (1992) 117-125
31. Fadda P., Pani L., Porcella A., and Fratta W. Chronic imipramine, 1-sulpride and mianserin decrease corticotropin releasing factor levels in the rat brain. Neurosci Letter 192 (1995) 121-123
32. Schule C., Baghai T.C., Eser D., Zwanzger P., Jordan M., Buechs R., and Rupprecht R. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology (Berl) 186 (2006) 601-611
33. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions. Mol Psychiatry 1 (1996) 336-342
34. Pariante C.M., and Miller A.H. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biol Psychiatry 49 (2001) 391-404
35. Pariante C.M. Glucocorticoid receptor function in vitro in patients with major depression. Stress 7 (2004) 209-219
36. Shea A.K., Streiner D.L., Flemin A., Kamath M.V., Broad K., and Steiner M. The effect of depression, anxiety and early life trauma on the cortisol awakening response during pregnancy: Preliminary results. Psychoneuroendocrinology 32 (2007) 1013-1020